NEW YORK (GenomeWeb) – PerkinElmer announced after the close of the market on Monday that it has acquired Tulip Diagnostics Private, a provider of in vitro diagnostic reagents, kits, and instruments to diagnostic labs, and government and private healthcare facilities in India.

The company expects the transaction to close in the first quarter of 2017. Further terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.